| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.19 | 0.006 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |